celecoxib has been researched along with Cancer, Second Primary in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Selenium and Celecoxib Trial was a randomized, placebo-controlled trial of once-daily selenium 200 µg and celecoxib 400 mg, alone or together, for colorectal adenoma prevention." | 9.22 | Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. ( Ahnen, DJ; Alberts, DS; Ashbeck, EL; Bhattacharyya, A; Boland, CR; Buckmeier, J; Chow, SH; Fales, L; Fay, DE; Hamilton, SR; Heigh, RI; Hsu, CH; Jacobs, ET; Lance, P; Martinez, EM; Roe, DJ; Thompson, PA; Wang, F, 2016) |
| "The Selenium and Celecoxib Trial was a randomized, placebo-controlled trial of once-daily selenium 200 µg and celecoxib 400 mg, alone or together, for colorectal adenoma prevention." | 5.22 | Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. ( Ahnen, DJ; Alberts, DS; Ashbeck, EL; Bhattacharyya, A; Boland, CR; Buckmeier, J; Chow, SH; Fales, L; Fay, DE; Hamilton, SR; Heigh, RI; Hsu, CH; Jacobs, ET; Lance, P; Martinez, EM; Roe, DJ; Thompson, PA; Wang, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, PA | 1 |
| Ashbeck, EL | 1 |
| Roe, DJ | 1 |
| Fales, L | 1 |
| Buckmeier, J | 1 |
| Wang, F | 1 |
| Bhattacharyya, A | 1 |
| Hsu, CH | 1 |
| Chow, SH | 1 |
| Ahnen, DJ | 1 |
| Boland, CR | 1 |
| Heigh, RI | 1 |
| Fay, DE | 1 |
| Hamilton, SR | 1 |
| Jacobs, ET | 1 |
| Martinez, EM | 1 |
| Alberts, DS | 1 |
| Lance, P | 1 |
| Psaty, BM | 1 |
| Potter, JD | 1 |
1 trial available for celecoxib and Cancer, Second Primary
| Article | Year |
|---|---|
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.
Topics: Adenoma; Aged; Cardiovascular Diseases; Celecoxib; Colonoscopy; Colorectal Neoplasms; Cyclooxygenase | 2016 |
1 other study available for celecoxib and Cancer, Second Primary
| Article | Year |
|---|---|
Risks and benefits of celecoxib to prevent recurrent adenomas.
Topics: Adenoma; Adenomatous Polyps; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celec | 2006 |